Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.


Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
09 2020
Historique:
received: 26 02 2020
accepted: 03 03 2020
pubmed: 21 8 2020
medline: 21 10 2021
entrez: 22 8 2020
Statut: ppublish

Résumé

Chronic non cirrhotic extrahepatic portal vein obstruction (EHPVO) refers to the cavernomatous transformation of the portal vein (the so-called "portal cavernoma") which occurs following acute thrombosis of the portal vein in the absence of recanalization. In adults, EHPVO mainly occurs following thrombosis, while in children it may be related to congenital malformations and/or neonatal umbilical venous catheterization. However, 50% of the cases of EHPVO remain idiopathic [1]. Risk factors and associated diseases should be investigated (chapter 1). Indeed, the presence of a thrombophilic alteration, in particular myeloproliferative neoplasm impacts prognosis and determine a causal treatment.

Identifiants

pubmed: 32819872
pii: S2210-7401(20)30091-7
doi: 10.1016/j.clinre.2020.03.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-496

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Laure Elkrief (L)

Department of Gastroenterology and Hepatology, Trousseau Hospital, University Hospital of Tours, Avenue de la République, 37170 Chambray-lès-Tours, France. Electronic address: laure_elkrief@yahoo.fr.

Pauline Houssel-Debry (P)

Department of liver disease, Pontchaillou Hospital, University Hospital of Rennes, 2, rue Henri le Guilloux 35033 Rennes cedex 9, France.

Oanez Ackermann (O)

Department of Pediatric Hepatology, Bicêtre Hospital, AP-HP, 78, rue du Général Leclerc 94270 Le Kremlin Bicêtre, France; French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.

Stéphanie Franchi-Abella (S)

Department of Pediatric Radiology, Bicêtre Hospital, AP-HP, 78, rue du Général Leclerc 94270 Le Kremlin Bicêtre, France; French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.

Sophie Branchereau (S)

Department of Pediatric Visceral Surgery, Bicêtre Hospital, AP-HP, 78, rue du Général Leclerc 94270 Le Kremlin Bicêtre, France.

Dominique Valla (D)

Department of Hepatology, DHU Unity, Beaujon Hospital, AP-HP, 100, boulevard du Général Leclerc 92118 Clichy, France; French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Reference center of vascular liver diseases, European Reference Network (ERN) Rare-Liver, Hamburg, Germany.

Sophie Hillaire (S)

Reference center of vascular liver diseases, European Reference Network (ERN) Rare-Liver, Hamburg, Germany.

Danielle Dutheil (D)

French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Department of Internal Medicine, Foch Hospital, 40, rue Worth, 92150 Suresnes, France; Association of patients with vascular liver diseases (AMVF), Beaujon Hospital, Department of Hepatology, 100, boulevard du Général Leclerc 92118 Clichy, France.

Aurélie Plessier (A)

Department of Hepatology, DHU Unity, Beaujon Hospital, AP-HP, 100, boulevard du Général Leclerc 92118 Clichy, France; French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Reference center of vascular liver diseases, European Reference Network (ERN) Rare-Liver, Hamburg, Germany.

Virginia Hernandez-Gea (V)

Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de IDIBAPS and CIBERehd, Barcelona, Spain.

Christophe Bureau (C)

French Network for Rare Liver Diseases (FILFOIE), Saint-Antoine Hospital, APHP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Department of Gastroenterology and Hepatology, Rangueil Hospital, University Hospital of Toulouse, 1, avenue du Professeur Jean Poulhès, 31400 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH